Conventional and Experimental Chemotherapy With Allogeneic Transplant in Young Patients With Acute Myeloid Leukaemia
Conditions
Acute Myeloid Leukemia
Conditions: official terms
Leukemia - Leukemia, Myeloid - Leukemia, Myeloid, Acute
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case-Only, Time Perspective: Retrospective
Overall Status
Recruiting
Summary
The purpose of this study is evaluate patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital. The purpose of data collection is to assess, with retrospective analysis, the clinical outcome divided by risk class and evaluated in patients who achieve complete remission after induction therapy and consolidation.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 66 Years
Minimum Age: 18 Years
Gender: Both
Criteria: Patients with acute myeloid leukemia (<=66 years), treated with conventional and experimental chemotherapy following allogeneic transplantation. THis patients have been enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.
Location
Città della Salute e della Scienza di Torino
Torino, Italy
Status: Recruiting
Contact: Benedetto Bruno, MD - +390116336728 - benedetto.bruno@unito.it
Start Date
February 2013
Completion Date
February 2014
Sponsors
Azienda Ospedaliera San Giovanni Battista
Source
Azienda Ospedaliera San Giovanni Battista
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page